Progression of low-grade dysplasia in ulcerative colitis: Effect of colonic location

Gastrointestinal Endoscopy

Volumn 74, Issue 5, 2011, Pages 1087-1093

  Goldstone, Robert ^a   Itzkowitz, Steven ^a   Harpaz, Noam ^a   Ullman, Thomas ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

advanced neoplasia (high grade dysplasia and or colorectal cancer); AN; colorectal cancer; CRC; hazard ratio; HGD; high grade dysplasia; HR; LGD; low grade dysplasia; primary sclerosing cholangitis; PSC; UC; ulcerative colitis

Indexed keywords

MERCAPTOPURINE; MESALAZINE;

ADULT; ADVANCED CANCER; ARTICLE; CANCER LOCALIZATION; CLINICAL ASSESSMENT; COLON BIOPSY; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASE FREE SURVIVAL; DRUG EXPOSURE; DYSPLASIA; FEMALE; FOLLOW UP; GASTROINTESTINAL DYSPLASIA; HIGH GRADE DYSPLASIA; HUMAN; LOW GRADE DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORPHOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 80054995764     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2011.06.028     Document Type: Article

References (45)

1. J.A. Eaden, K.R. Abrams, and J.F. Mayberry The risk of colorectal cancer in ulcerative colitis: a meta-analysis Gut 48 2001 526 535
2. M.D. Rutter, B.P. Saunders, and K.H. Wilkinson Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis Gastroenterology 130 2006 1030 1038
3. S.N. Gyde, P. Prior, and R.N. Allan Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres Gut 29 1988 206 217
4. A. Ekbom, C. Helmick, and M. Zack Ulcerative colitis and colorectal cancer A population-based study N Engl J Med 323 1990 1228 1233
5. R.M. Soetikno, O.S. Lin, and P.A. Heidenreich Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis Gastrointest Endosc 56 2002 48 54
6. U. Broome, R. Lofberg, and B. Veress Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential Hepatology 22 1995 1404 1408
7. K.W. Nuako, D.A. Ahlquist, and D.W. Mahoney Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study Gastroenterology 115 1998 1079 1083
8. J. Askling, P.W. Dickman, and P. Karlen Family history as a risk factor for colorectal cancer in inflammatory bowel disease Gastroenterology 120 2001 1356 1362
9. R.B. Gupta, N. Harpaz, and S. Itzkowitz Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study Gastroenterology 133 2007 1099 1105 quiz 1340-1
10. M. Rutter, B. Saunders, and K. Wilkinson Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis Gastroenterology 126 2004 451 459
11. B.A. Lashner, B.C. Turner, and D.G. Bostwick Dysplasia and cancer complicating strictures in ulcerative colitis Dig Dis Sci 35 1990 349 352
12. M.D. Rutter, B.P. Saunders, and K.H. Wilkinson Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk Gut 53 2004 1813 1816
13. R.H. Riddell, H. Goldman, and D.F. Ransohoff Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications Hum Pathol 14 1983 931 968
14. S.H. Itzkowitz, and N. Harpaz Diagnosis and management of dysplasia in patients with inflammatory bowel diseases Gastroenterology 126 2004 1634 1648
15. N. Harpaz, and A.D. Polydorides Colorectal dysplasia in chronic inflammatory bowel disease: pathology, clinical implications, and pathogenesis Arch Pathol Lab Med 134 2010 876 895
16. C.N. Bernstein, F. Shanahan, and W.M. Weinstein Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 343 1994 71 74
17. W.R. Connell, J.E. Lennard-Jones, and C.B. Williams Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis Gastroenterology 107 1994 934 944
18. T. Ullman, V. Croog, and N. Harpaz Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis Gastroenterology 125 2003 1311 1319
19. C.H. Lim, M.F. Dixon, and A. Vail Ten year follow up of ulcerative colitis patients with and without low grade dysplasia Gut 52 2003 1127 1132
20. R. Befrits, T. Ljung, and E. Jaramillo Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study Dis Colon Rectum 45 2002 615 620
21. T.A. Ullman, E.V. Loftus Jr, and S.B. Kakar The fate of low grade dysplasia in ulcerative colitis Am J Gastroenterol 97 2002 922 927
22. F.E. Rijcken, H. Hollema, and J.H. Kleibeuker Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation Gut 50 2002 382 386
23. C. Azzoni, L. Bottarelli, and N. Campanini Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis Int J Colorectal Dis 22 2007 115 126
24. F. Benedix, R. Kube, F. Meyer Colon/Rectum Carcinomas (Primary Tumors) Study Group Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival Dis Colon Rectum 53 2010 57 64
25. N.N. Baxter, M.A. Goldwasser, and L.F. Paszat Association of colonoscopy and death from colorectal cancer Ann Intern Med 150 2009 1 8
26. T. Ullman, V. Croog, and N. Harpaz Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine Clin Gastroenterol Hepatol 6 2008 1225 1230 quiz 1177
27. B.U. Lindberg, U. Broome, and B. Persson Proximal colorectal dysplasia or cancer in ulcerative colitis The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study Dis Colon Rectum 44 2001 77 85
28. P.M. Choi Predominance of rectosigmoid neoplasia in ulcerative colitis and its implication on cancer surveillance Gastroenterology 104 1993 666 667
29. A.J. Woolrich, M.D. DaSilva, and B.I. Korelitz Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia Gastroenterology 103 1992 431 438
30. S.H. Itzkowitz, and D.H. Present Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease Inflamm Bowel Dis 11 2005 314 321
31. F.A. Farraye, R.D. Odze, and J. Eaden AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease Gastroenterology 138 2010 746 774 774 e1-4; quiz e12-3
32. T. Jess, E.V. Loftus Jr, and F.S. Velayos Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota Inflamm Bowel Dis 12 2006 669 676
33. H. Brenner, J. Chang-Claude, and C.M. Seiler Does a negative screening colonoscopy ever need to be repeated? Gut 55 2006 1145 1150
34. L. Shen, M. Toyota, and Y. Kondo Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer Proc Natl Acad Sci U S A 104 2007 18654 18659
35. R. Kiesslich, and M.I. Canto Confocal laser endomicroscopy Gastrointest Endosc Clin N Am 19 2009 261 272
36. R. Kiesslich, and M.F. Neurath What new endoscopic imaging modalities will become important in the diagnosis of IBD? Inflamm Bowel Dis 14 Suppl 2 2008 S172 S176
37. J.F. Marion, J.D. Waye, and D.H. Present Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial Am J Gastroenterol 103 2008 2342 2349
38. M.D. Rutter, B.P. Saunders, and K.H. Wilkinson Most dysplasia in ulcerative colitis is visible at colonoscopy Gastrointest Endosc 60 2004 334 339
39. D.T. Rubin, J.A. Rothe, and J.T. Hetzel Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc 65 2007 998 1004
40. P.H. Rubin, S. Friedman, and N. Harpaz Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps Gastroenterology 117 1999 1295 1300
41. M. Engelsgjerd, F.A. Farraye, and R.D. Odze Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis Gastroenterology 117 1999 1288 1294 discussion 1488-91
42. S. Friedman, R.D. Odze, and F.A. Farraye Management of neoplastic polyps in inflammatory bowel disease Inflamm Bowel Dis 9 2003 260 266
43. R.D. Odze Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological, and molecular review Am J Gastroenterol 94 1999 1746 1750
44. C.N. Bernstein, W.M. Weinstein, and D.S. Levine Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis Am J Gastroenterol 90 1995 2106 2114
45. J.A. Eaden, B.A. Ward, and J.F. Mayberry How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance Gastrointest Endosc 51 2000 123 128